Prognostic value of human chorionic gonadotropin changes after methotrexate injection for ectopic pregnancy

Fertility and Sterility

Volumn 88, Issue 2, 2007, Pages 504-506

  Agostini, Aubert ^a   Blanc, Karina ^a   Ronda, Isabelle ^a   Romain, Fanny ^a   Capelle, Mariane ^a   Blanc, Bernard ^a  

^a HÔPITAL DE LA CONCEPTION   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; METHOTREXATE;

ADULT; ARTICLE; CLINICAL PROTOCOL; DRUG SAFETY; ECTOPIC PREGNANCY; FEMALE; FOLLOW UP; FRANCE; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SINGLE DRUG DOSE;

ABORTIFACIENT AGENTS, NONSTEROIDAL; CHORIONIC GONADOTROPIN; FEMALE; HUMANS; INJECTIONS; METHOTREXATE; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TESTS; PREGNANCY, ECTOPIC; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 34547655601     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.11.138     Document Type: Article

References (15)

1. Coste J., Bouyer J., Ughetto S., Gerbaud L., Fernandez H., Pouly J.L., et al. Ectopic pregnancy is again on the increase. Recent trends in the incidence of ectopic pregnancies in France (1992-2002). Hum Reprod 19 (2004) 2014-2018
2. Romero R., Kadar N., Copel J.A., Jeanty P., DeCherney A.H., and Hobbins J.C. The value of serial human chorionic gonadotropin testing as a diagnostic tool in ectopic pregnancy. Am J Obstet Gynecol 155 (1986) 392-394
3. Nyberg D.A., Filly R.A., Laing F.C., Mack L.A., and Zarutskie P.W. Ectopic pregnancy. Diagnosis by sonography correlated with quantitative HCG levels. J Ultrasound Med 6 (1987) 145-150
4. Barnhart K.T., Simhan H., and Kamelle S.A. Diagnostic accuracy of ultrasound above and below the beta-hCG discriminatory zone. Obstet Gynecol 94 (1999) 583-587
5. Stovall T.G., Ling F.W., and Gray L.A. Single-dose methotrexate for treatment of ectopic pregnancy. Obstet Gynecol 77 (1991) 754-757
6. Stovall T., Ling F., Carson S., and Buster J. Non surgical diagnosis and treatment of tubal pregnancy. Fertil Steril 54 (1990) 537-538
7. Lipscomb G.H., Givens V.A., Meyer N.L., and Bran D. Previous ectopic pregnancy as a predictor of failure of systemic methotrexate therapy. Fertil Steril 81 (2004) 1221-1224
8. Fernandez H., Lelaidier C., Thouvenez V., and Frydman R. The use of a pretherapeutic predictive score to determine inclusion criteria for the non-surgical treatment of ectopic pregnancy. Hum Reprod 6 (1991) 995-998
9. Stovall T.G., and Ling F.W. Ectopic pregnancy. Diagnostic and therapeutic algorithms minimizing surgical intervention. J Reprod Med 38 (1993) 807-812
10. Lipscomb G.H., McCord M.L., Stovall T.G., Huff G., Portera S.G., and Ling F.W. Predictors of success of methotrexate treatment in women with tubal ectopic pregnancies. N Engl J Med 341 (1999) 1974-1978
11. Stovall T.G. Medical management should be routinely used as primary therapy for ectopic pregnancy. Clin Obstet Gynecol 38 (1995) 346-352
12. Dudley P.S., Heard M.J., Sangi-Haghpeykar H., Carson S.A., and Buster J.E. Characterizing ectopic pregnancies that rupture despite treatment with methotrexate. Fertil Steril 82 (2004) 1374-1378
13. Fernandez H., Benifla J.L., Lelaidier C., Baton C., and Frydman R. Methotrexate treatment of ectopic pregnancy: 100 cases treated by primary transvaginal injection under sonographic control. Fertil Steril 59 (1993) 773-777
14. Lewis-Bliehall C., Rogers R.G., Kammerer-Doak D.N., Conway S.C., Amaya C., and Byrn F. Medical vs. surgical treatment of ectopic pregnancy. The University of New Mexico's six-year experience. J Reprod Med 46 (2001) 983-988
15. Nelson A.L., Adams Y., Nelson L.E., and Lahue A.K. Ambulatory diagnosis and medical management of ectopic pregnancy in a public teaching hospital serving indigent women. Am J Obstet Gynecol 188 (2003) 1541-1547